{"id":"https://openalex.org/W2399794824","doi":"https://doi.org/10.1002/psp4.12081","title":"Prospective Design of Anti\u2010Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain","display_name":"Prospective Design of Anti\u2010Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2399794824","doi":"https://doi.org/10.1002/psp4.12081","mag":"2399794824","pmid":"https://pubmed.ncbi.nlm.nih.gov/27299941","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4879477"},"language":"en","primary_location":{"id":"doi:10.1002/psp4.12081","doi":"https://doi.org/10.1002/psp4.12081","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.12081","pdf_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12081","source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12081","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065208301","display_name":"JS Kanodia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JS Kanodia","raw_affiliation_strings":["Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076530200","display_name":"Kapil G. Gadkar","orcid":"https://orcid.org/0009-0008-0911-2179","observed_orcids":["https://orcid.org/0009-0008-0911-2179"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Gadkar","raw_affiliation_strings":["Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070377113","display_name":"Daniela Bumbaca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Bumbaca","raw_affiliation_strings":["Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020123474","display_name":"Y Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y Zhang","raw_affiliation_strings":["Antibody Engineering Department, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Engineering Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027587324","display_name":"RK Tong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RK Tong","raw_affiliation_strings":["Protein Sciences, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Sciences, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067272210","display_name":"Wilman Luk","orcid":"https://orcid.org/0000-0003-2627-4547","observed_orcids":["https://orcid.org/0000-0003-2627-4547"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W Luk","raw_affiliation_strings":["Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072544111","display_name":"Kwame Hoyte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Hoyte","raw_affiliation_strings":["Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088245618","display_name":"Yanmei Lu","orcid":"https://orcid.org/0000-0002-2772-5154","observed_orcids":["https://orcid.org/0000-0002-2772-5154"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y Lu","raw_affiliation_strings":["Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056123491","display_name":"KR Wildsmith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"KR Wildsmith","raw_affiliation_strings":["Biomarker Development, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomarker Development, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111559976","display_name":"JA Couch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JA Couch","raw_affiliation_strings":["Safety Assessment, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"RJ Watts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RJ Watts","raw_affiliation_strings":["Department of Neuroscience, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112135557","display_name":"MS Dennis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MS Dennis","raw_affiliation_strings":["Antibody Engineering Department, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antibody Engineering Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"JA Ernst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JA Ernst","raw_affiliation_strings":["Protein Sciences, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Sciences, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022932542","display_name":"Kimberly A. Scearce-Levie","orcid":"https://orcid.org/0000-0003-0568-802X","observed_orcids":["https://orcid.org/0000-0003-0568-802X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Scearce\u2010Levie","raw_affiliation_strings":["Department of Neuroscience, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058782466","display_name":"JK Atwal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JK Atwal","raw_affiliation_strings":["Department of Neuroscience, Genentech, South San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102952342","display_name":"Saroja Ramanujan","orcid":"https://orcid.org/0000-0002-0909-9786","observed_orcids":["https://orcid.org/0000-0002-0909-9786"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S Ramanujan","raw_affiliation_strings":["Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036730904","display_name":"Sean B. Joseph","orcid":"https://orcid.org/0000-0002-2602-8517","observed_orcids":["https://orcid.org/0000-0002-2602-8517"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Joseph","raw_affiliation_strings":["Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical and Translational Pharmacokinetics Department, Genentech, South San Francisco, California, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Jitendra S. Kanodia, Kapil Gadkar, Saroja Ramanujan, and Sean Joseph contributed equally to this work","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102952342"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":4140,"currency":"USD","value_usd":4140},"apc_paid":{"value":4140,"currency":"USD","value_usd":4140},"fwci":2.0085,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.85201244,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"5","issue":"5","first_page":"283","last_page":"291"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.8237000107765198,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.8237000107765198,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1363999992609024,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bace1","display_name":"BACE1","score":0.6349999904632568},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.7310000061988831},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.6600000262260437},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.6980000138282776},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.8090000152587891},{"id":"https://openalex.org/keywords/alzheimer-s-disease-therapeutics","display_name":"Alzheimer's disease therapeutics","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C32264632","wikidata":"https://www.wikidata.org/wiki/Q1134983","display_name":"Transferrin receptor","level":3,"score":0.7717914581298828},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7662176489830017},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.6295697689056396},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5758598446846008},{"id":"https://openalex.org/C22814914","wikidata":"https://www.wikidata.org/wiki/Q410473","display_name":"Transferrin","level":2,"score":0.47518956661224365},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4749710261821747},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.47109824419021606},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.44953587651252747},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.42026543617248535},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4197171926498413},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3646189272403717},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3523637056350708},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3462405204772949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3178965449333191},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26979073882102966},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.25303998589515686},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15777426958084106},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.1502590775489807}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011990","descriptor_name":"Receptors, Transferrin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011990","descriptor_name":"Receptors, Transferrin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/psp4.12081","doi":"https://doi.org/10.1002/psp4.12081","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.12081","pdf_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12081","source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3878762","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4879477","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4879477","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4879477","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT Pharmacometrics Syst Pharmacol","raw_type":"Text"},{"id":"pmid:27299941","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27299941","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: pharmacometrics & systems pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/psp4.12081","doi":"https://doi.org/10.1002/psp4.12081","is_oa":true,"landing_page_url":"https://doi.org/10.1002/psp4.12081","pdf_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/psp4.12081","source":{"id":"https://openalex.org/S4210231731","display_name":"CPT Pharmacometrics & Systems Pharmacology","issn_l":"2163-8306","issn":["2163-8306"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CPT: Pharmacometrics & Systems Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2399794824.pdf","grobid_xml":"https://content.openalex.org/works/W2399794824.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1596612421","https://openalex.org/W1946081631","https://openalex.org/W1968030422","https://openalex.org/W1995017657","https://openalex.org/W2025061302","https://openalex.org/W2026422955","https://openalex.org/W2028231726","https://openalex.org/W2048428129","https://openalex.org/W2071079524","https://openalex.org/W2096735751","https://openalex.org/W2100276489","https://openalex.org/W2104329573","https://openalex.org/W2106477295","https://openalex.org/W2109364787","https://openalex.org/W2109699895","https://openalex.org/W2130255055","https://openalex.org/W2136321415","https://openalex.org/W2138037217","https://openalex.org/W2140073946","https://openalex.org/W2144232916","https://openalex.org/W2144370915","https://openalex.org/W2149269973","https://openalex.org/W2161304688","https://openalex.org/W2162676548","https://openalex.org/W2171259749","https://openalex.org/W2252006103","https://openalex.org/W2261912426","https://openalex.org/W2292737110"],"related_works":["https://openalex.org/W2252006103","https://openalex.org/W4411669284","https://openalex.org/W4363645516","https://openalex.org/W4407698698","https://openalex.org/W4247532241","https://openalex.org/W2100276489","https://openalex.org/W4413400829","https://openalex.org/W4416607638","https://openalex.org/W2109699895","https://openalex.org/W4210369877"],"abstract_inverted_index":{"Anti-transferrin":[0],"receptor":[1],"(TfR)-based":[2],"bispecific":[3,75,145],"antibodies":[4,77,114],"have":[5],"shown":[6],"promise":[7],"for":[8,27,74,80,138,143,152],"boosting":[9],"antibody":[10],"uptake":[11,46],"in":[12,115,130],"the":[13,21,41,52,84,91,103,116,124],"brain.":[14],"Nevertheless,":[15],"there":[16],"are":[17],"limited":[18],"data":[19],"on":[20],"molecular":[22],"properties,":[23],"including":[24,147],"affinity":[25,39,106,126],"required":[26,107],"successful":[28],"development":[29],"of":[30,40,55,95,112,127,149],"TfR-based":[31],"therapeutics.":[32],"A":[33],"complex":[34],"nonmonotonic":[35],"relationship":[36,57],"exists":[37],"between":[38],"anti-TfR":[42,105,128,144],"arm":[43],"and":[44,58,119],"brain":[45,110],"at":[47,83],"therapeutically":[48],"relevant":[49],"doses.":[50],"However,":[51],"quantitative":[53],"nature":[54],"this":[56,133],"its":[59],"translatability":[60],"to":[61,108,122],"humans":[62],"is":[63],"heretofore":[64],"unexplored.":[65],"Therefore,":[66],"we":[67],"developed":[68],"a":[69,136],"mechanistic":[70],"pharmacokinetic-pharmacodynamic":[71],"(PK-PD)":[72],"model":[73,100,134],"anti-TfR/BACE1":[76],"that":[78],"accounts":[79],"antibody-TfR":[81],"interactions":[82],"blood-brain":[85],"barrier":[86],"(BBB)":[87],"as":[88,90],"well":[89],"pharmacodynamic":[92],"(PD)":[93],"effect":[94],"anti-BACE1":[96],"arm.":[97],"The":[98],"calibrated":[99],"correctly":[101],"predicted":[102],"optimal":[104,125],"maximize":[109],"exposure":[111],"therapeutic":[113],"cynomolgus":[117],"monkey":[118],"was":[120],"scaled":[121],"predict":[123],"bispecifics":[129],"humans.":[131],"Thus,":[132],"provides":[135],"framework":[137],"testing":[139],"critical":[140],"translational":[141],"predictions":[142],"antibodies,":[146],"choice":[148],"candidate":[150],"molecule":[151],"clinical":[153],"development.":[154]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}